<DOC>
	<DOCNO>NCT02668432</DOCNO>
	<brief_summary>Purpose/Objectives : Severe sepsis septic shock common cause new onset atrial fibrillation ( NOAF ) intensive care unit . Development NOAF set prolong length stay increase mortality . Amiodarone commonly use agent use set control rate rhythm . However , limited data exist detail appropriate dose setting . The primary objective study evaluate two amiodarone dose strategy , full loading dose versus partial loading dose , patient new-onset atrial fibrillation ( AF ) due severe sepsis septic shock ass mean heart rate every 6 hour initiation amiodarone infusion day 7 death . Research Design/Plan : Consecutive patient admit medical cardiac intensive care unit University Hospital NOAF set severe sepsis septic shock screen study inclusion . Data collect stored use Microsoft Excel Access analyze JMP 12.0 SPSS . Methods : Patients age 18 year old develop new-onset atrial fibrillation set severe sepsis septic shock medical team deems appropriate initiate amiodarone therapy consider study inclusion . Patients receive intravenous ( IV ) oral ( PO ) amiodarone , per standard care . Patients randomize certain quantitative loading dose strategy ; either full loading dose ( ≥ 5g IV ≥10g PO +/- 20 % ) partial load dose ( &lt; 4g IV &lt; 8g PO ) . Clinical Relevance : With intensive care unit length stay ( ICU LOS ) mortality twice high NOAF sepsis compare septic patient without NOAF , investigator ultimately aim identify management strategy may minimize morbidity mortality also minimize exposure drug may cause serious adverse effect .</brief_summary>
	<brief_title>Use Amiodarone Atrial Fibrillation Associated With Severe Sepsis Septic Shock</brief_title>
	<detailed_description>Step-by-Step Methods : Population : The study conduct University Hospital , 716-bed county hospital Bexar County serve varied population , include patient medically underserved area . The patient population come medical intensive care unit cardiac intensive care unit , 20 26-bed unit , respectively , University Hospital clinical practice teach site one study investigator . Screening : Consecutive patient admit medical cardiac intensive care unit University Hospital new onset atrial fibrillation set severe sepsis septic shock screen study inclusion . Participants 18 year old . Patients develop new-onset atrial fibrillation set severe sepsis septic shock consider study inclusion . Exclusion criterion apply young 18 year age , history atrial flutter , baseline QTc &gt; 500 msec , atrial fibrillation index admission past medical history , second third degree atrioventricular ( AV ) block , recover cardiac surgery do hospital admission , receive amiodarone Vaughan Williams class I III antiarrhythmic drug last 6 month , untreated/poorly control hypothyroidism , hyperthyroidism , acute chronic hepatic failure , requirement antiarrhythmic drug therapy , recent cardiac surgery precede 30 day , pregnant . Intervention : Patients age 18 year old develop new-onset atrial fibrillation set severe sepsis septic shock medical team deems appropriate initiate amiodarone therapy consider study inclusion . All patient receive 150 mg IV bolus dose amiodarone , follow immediately continuous infusion 1 mg/min first six hour , recommend reduction 0.5 mg/min subsequently . Conversion IV PO amiodarone occur base patient hemodynamic stability physician/pharmacist discretion . Patients randomize receive amiodarone full loading dose ( ≥ 5g IV ≥10g PO +/- 20 % ) partial load dose ( &lt; 4g IV &lt; 8g PO ) . The assigned total load dose include IV PO amiodarone administer within 7 day initiation amiodarone . All dos compare total PO amount ( account 50 % bioavailability PO versus IV amiodarone ) . The primary attending fellow physician may over-ride randomization patient 's amiodarone dose patient 's severity illness warrant duration differs assign randomization . In full loading dose group , discontinuation amiodarone discretion physician/pharmacists , pre-determined randomization load dose provide . Management Components : Facilities use throughout project include University Hospital The University Texas Health Science Center San Antonio . Equipment use direct patient care keep standards-of-care , without additional equipment require clinical research study . Data Collection : Data collection include age , race , gender , body mass index ( BMI ) , data calculate Acute Physiology Chronic Health Evaluation ( APACHE II ) Sequential Organ Failure Assessment ( SOFA ) score , suspect source infection , identify pathogen , pre-existing condition may predispose patient AF severity/classification illness ( coronary artery disease , heart failure , chronic kidney disease , chronic obstructive pulmonary disease , diabetes mellitus ) ; vital sign onset AF ( mean arterial pressure , systolic blood pressure , heart rate ) , lactate , pH , serum bicarbonate time AF onset ; fluid resuscitation volume 24 hour prior AF , vasopressor use ( include drug , dose , duration ) precede 24 hour ; medication use stabilize hemodynamic status AF ( e.g . β-blockers , calcium channel blocker , digoxin ) , attempt method cardioversion attempt prior amiodarone use ( e.g . direct current cardioversion , antiarrhythmic drug therapy ) ; amiodarone load dose , cumulative study amiodarone dose ; duration time spend AF conversion normal sinus rhythm ( NSR ) , incidence AF recurrence ; hemodynamic variable assess various time point initiation amiodarone ( -6 hour , onset AF , 2 hour , 6 hour , 12 hour , every 6 hour thereafter day 7 death ) include mean arterial pressure , central venous pressure , systolic blood pressure , heart rate , pH , serum bicarbonate , serum lactate . Monitoring Efficacy Safety : Efficacy : Patients stratify base response therapy one three group : conversion NSR , non-converting AF hemodynamically stable non-converting AF hemodynamically unstable . The primary efficacy outcome mean heart rate every 6 hour initiation amiodarone infusion day 7 death . Secondary efficacy endpoint include percentage time spend hemodynamically unstable first 7 day follow amiodarone initiation , ICU LOS , hospital LOS 28-day mortality along comparison individual portion hemodynamic endpoint [ mean arterial pressure ( MAP ) , heart rate ( HR ) , systolic blood pressure ( SBP ) ] , cumulative vasopressor dos norepinephrine vasopressin , central venous pressure ( CPR ) , conversion NSR , maintenance NSR , proportion time spend NSR start infusion day 7 death , pH , standard bicarbonate , serum lactate , central venous oxygen saturation . Safety : Safety outcome include worsen hypotension ( largely relate rate infusion polysorbate 80 diluent ) , bradycardia , acute elevation liver function test ≥ 3 time upper limit normal , phlebitis , QTc prolongation , skin reaction , neuropathy , pulmonary toxicity . We also collect premature study discontinuation due adverse event . Because experimental group study partial load amiodarone , rather full load , likely experimental group experience few amiodarone related adverse effect receive current practice . In set worsen hemodynamic stability amiodarone infusion ( i.e . SBP &lt; 90 mmHg OR MAP &lt; 70 mmHg , despite HR control &lt; 120 bpm ; need fluid bolus ± vasopressor dobutamine ) , medical team believe cause IV amiodarone therapy : 1. amiodarone infusion rate decrease 50 % , effort increase back standard infusion rate patient hemodynamically stable , 2. switch IV amiodarone PO amiodarone therapy dose 400 mg PO three time daily ( TID ) , 3. emergent electro-cardioversion discretion medical team ( standard care ) Data Analysis Plan : Data collect stored use Microsoft Excel Access . After data organization cleaning , data import JMP 12.0 SPSS . Data analyze use descriptive comparative statistic . The primary outcome analyze use repeat measure ANOVA . Nominal ordinal variable compare use Chi-square test Fisher 's Exact test , appropriate . Continuous variable test normality use Shapiro-Wilk W goodness fit test . Continuous variable normal distribution compare use student 's t-test , non-parametric variable compare use Wilcoxon rank sum test . Statistical significance define alpha level less 0.05 . All baseline demographic , include patient comorbidities , amount fluid resuscitation , previous vasoactive therapy , use intervention direct current cardioversion , enter multivariate regression model p value le 0.20 univariate comparison treatment group . The multivariate regression model use assess baseline factor previous treatment intervention affect study outcome . Based extrapolation available literature assess HR control 24 hour , estimate full load dose group mean HR 110 bpm course 7 day , partial load dose group mean HR 130 bpm course 7 day . 7 day mean HR 20 bpm lower partial load dose group . Therefore , estimate 250 patient necessary group 85 % power detect difference , assume 15 % drop-out rate .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Shock</mesh_term>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Amiodarone</mesh_term>
	<criteria>New onset atrial fibrillation Severe sepsis septic shock ( define ≥2 systemic inflammatory response syndrome criterion + infection ) Age &lt; 18 year History atrial flutter History atrial fibrillation QTc &gt; 500 msec baseline 2nd 3rd degree AV block Currently receive antiarrhythmic therapy Untreated thyroid dysfunction Acute chronic hepatic failure Other indication antiarrhythmic therapy Recent cardiac surgery last 30 day Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>